Dr. Lili Zhang, Ph.D. is an accomplished translational neuroscientist with 25+ years of experience in CNS drug development, IND-enabling studies, and strategic regulatory planning. Her contributions span multiple therapeutic programs in neurodegenerative diseases at biopharmaceutical companies including Novartis, Merck and emerging biotech companies.